In view of the observed differences in the pharmacokinetic profiles for sugar-coated tablets, soft gelatin capsules and ibuprofen lysinate tablets, this has to be considered as the result of one ...

Sulodexide is under clinical development by Alfasigma and currently in Phase III for Venous Thromboembolism. According to GlobalData, Phase III drugs for Venous Thromboembolism have a 60% phase ...

[4] The primary objective of this study was to assess bioequivalence between a new ibuprofen soft gelatin capsule formulation and the standard 200mg sugar-coated tablets. This patented new ...